drugset / Trial / NCT03217565
A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The primary objectives of this study are to describe the single-dose, and multiple dose pharmacokinetics (PK) of intravenous (IV) tedizolid phosphate, or a single dose oral suspension of tedizolid phosphate, when administered to pediatric participants, full-term neonates, and preterm neonates.
Timeline
- Start
- 2019-02-06
- Primary completion
- 2023-03-18
- Completion
- 2023-04-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tedizolid Phosphate | Small molecule | 2.5 mg/kg | Intravenous |
| Subject | Tedizolid Phosphate | Small molecule | 3 mg/kg | Intravenous |